Quantification of dopamine D2/3 receptors in rat brain using factor analysis corrected [18F]Fallypride images

NeuroImage

Volumn 62, Issue 3, 2012, Pages 1455-1468

  Millet, Philippe ^a   Moulin Sallanon, Marcelle ^a,b   Tournier, Benjamin B ^a,c   Dumas, Noé ^a   Charnay, Yves ^a   Ibáñez, Vicente ^a   Ginovart, Nathalie ^a,c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b INSERM   (France)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Dopamine D2 3 receptors; Factor analysis; Fallypride; Kinetic modeling; PET

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FALLYPRIDE F 18; FLUORINE 18; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL BLOOD; ARTICLE; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; EXTRASTRIATE BODY AREA; FACTORIAL ANALYSIS; KINEMATICS; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RADIODIAGNOSTIC EQUIPMENT AND SUPPLIES; RAT; SIMULATION;

ANIMALS; BENZAMIDES; BRAIN; BRAIN CHEMISTRY; FACTOR ANALYSIS, STATISTICAL; FLUORINE RADIOISOTOPES; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TISSUE DISTRIBUTION;

EID: 84863500875     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.05.075     Document Type: Article

References (47)

1. Aston J.A., Cunningham V.J., Asselin M.C., Hammers A., Evans A.C., Gunn R.N. Positron emission tomography partial volume correction: estimation and algorithms. J. Cereb. Blood Flow Metab. 2002, 22:1019-1034.
2. Benali H., Buvat I., Frouin F., Bazin J.P., Di Paola R. A statistical model for the determination of the optimal metric in factor analysis of medical image sequences (FAMIS). Phys. Med. Biol. 1993, 38:1065-1080.
3. Buvat I., Benali H., Frouin F., Bazin J.P., Di Paola R. Target apex-seeking in factor analysis of medical image sequences. Phys. Med. Biol. 1993, 38:123-138.
4. Buvat I., Benali H., Di Paola R. Statistical distribution of factors and factor images in factor analysis of medical image sequences. Phys. Med. Biol. 1998, 43:1695-1711.
5. Carson R.E., Wu Y., Lang L., Ma Y., Der M.G., Herscovitch P., Eckelman W.C. Brain uptake of the acid metabolites of F-18-labeled WAY 100635 analogs. J. Cereb. Blood Flow Metab. 2003, 23:249-260.
6. Christian B.T., Narayanan T.K., Shi B., Mukherjee J. Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [(18)F]fallypride in nonhuman primates. Synapse 2000, 38:71-79.
7. Christian B.T., Narayanan T., Shi B., Morris E.D., Mantil J., Mukherjee J. Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol. J. Cereb. Blood Flow Metab. 2004, 24:309-322.
8. Constantinescu C.C., Coleman R.A., Pan M.L., Mukherjee J. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [(18)F]fallypride and [(18)F]desmethoxyfallypride. Synapse 2011, 65:778-787.
9. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K., Pena Y., Murphy E.R., Shah Y., Probst K., Abakumova I., Aigbirhio F.I., Richards H.K., Hong Y., Baron J.C., Everitt B.J., Robbins T.W. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
10. Del Guerra A., Bartoli A., Belcari N., Herbert D., Motta A., Vaiano A., Di Domenico G., Sabba N., Moretti E., Zavattini G., Lazzarotti M., Sensi L., Larobina M., Uccelli L. Performance evaluation of the fully engineered YAP-(S)PET scanner for small animal imaging. IEEE Trans. Nucl. Sci. 2006, 53:1078-1083.
11. Delforge J., Bottlaender M., Loc'h C., Guenther I., Fuseau C., Bendriem B., Syrota A., Maziere B. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J. Cereb. Blood Flow Metab. 1999, 19:533-546.
12. Di Paola R., Bazin J.P., Aubry F., Aurengo A., Cavailloles F., Herry J.Y., Kahn E. Handling of dynamic sequences in nuclear medicine. IEEE Trans Nucl. Sci. 1982, NS29:1310-1321.
13. Dupont P., Warwick J. Kinetic modelling in small animal imaging with PET. Methods 2009, 48:98-103.
14. Fang Y.H., Muzic R.F. Spillover and partial-volume correction for image-derived input functions for small-animal 18F-FDG PET studies. J. Nucl. Med. 2008, 49:606-614.
15. Frouin F., De Cesare A., Bouchareb Y., Todd-Pokropek A., Herment A. Spatial regularization applied to factor analysis of medical image sequences (FAMIS). Phys. Med. Biol. 1999, 44:2289-2306.
16. Frouin F., Delouche A., Raffoul H., Diebold H., Abergel E., Diebold B. Factor analysis of the left ventricle by echocardiography (FALVE): a new tool for detecting regional wall motion abnormalities. Eur. J. Echocardiogr. 2004, 5:335-346.
17. Hayakawa N., Uemura K., Ishiwata K., Shimada Y., Ogi N., Nagaoka T., Toyama H., Oda K., Tanaka A., Endo K., Senda M. A PET-MRI registration technique for PET studies of the rat brain. Nucl. Med. Biol. 2000, 27:121-125.
18. Kim K.M., Watabe H., Kawachi N., Iida H. Extraction of blood pool in dynamic O-15 water PET with slow-infusion using factor analysis. Nuclear Science Symposium Conference Record, 2003 IEEE 2003, vol. 2644:2640-2641.
19. Kim J., Herrero P., Sharp T., Laforest R., Rowland D.J., Tai Y.C., Lewis J.S., Welch M.J. Minimally invasive method of determining blood input function from PET images in rodents. J. Nucl. Med. 2006, 47:330-336.
20. Kimura Y., Simeon F.G., Hatazawa J., Mozley P.D., Pike V.W., Innis R.B., Fujita M. Biodistribution and radiation dosimetry of a positron emission tomographic ligand, 18F-SP203, to image metabotropic glutamate subtype 5 receptors in humans. Eur. J. Nucl. Med. Mol. Imaging 2010, 37:1943-1949.
21. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
22. Meltzer C.C., Kinahan P.E., Greer P.J., Nichols T.E., Comtat C., Cantwell M.N., Lin M.P., Price J.C. Comparative evaluation of MR-based partial-volume correction schemes for PET. J. Nucl. Med. 1999, 40:2053-2065.
23. Millet P., Moulin M., Bartoli A., Del Guerra A., Ginovart N., Lemoucheux L., Buono S., Fagret D., Charnay Y., Ibanez V. In vivo quantification of 5-HT1A-[18F]MPPF interactions in rats using the YAP-(S)PET scanner and a beta-microprobe. Neuroimage 2008, 41:823-834.
24. Mukherjee J., Christian B.T., Dunigan K.A., Shi B., Narayanan T.K., Satter M., Mantil J. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse 2002, 46:170-188.
25. Mukherjee J., Shi B., Christian B.T., Chattopadhyay S., Narayanan T.K. 11C-Fallypride: radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain. Bioorg. Med. Chem. 2004, 12:95-102.
26. Mukherjee J., Christian B.T., Narayanan T.K., Shi B., Collins D. Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET. Brain Res. 2005, 1032:77-84.
27. Muller-Gartner H.W., Links J.M., Prince J.L., Bryan R.N., McVeigh E., Leal J.P., Davatzikos C., Frost J.J. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J. Cereb. Blood Flow Metab. 1992, 12:571-583.
28. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego. fourth edition.
29. Riccardi P., Baldwin R., Salomon R., Anderson S., Ansari M.S., Li R., Dawant B., Bauernfeind A., Schmidt D., Kessler R. Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride. Biol. Psychiatry 2008, 63:241-244.
30. Rominger A., Mille E., Zhang S., Boning G., Forster S., Nowak S., Gildehaus F.J., Wangler B., Bartenstein P., Cumming P. Validation of the octamouse for simultaneous 18F-fallypride small-animal PET recordings from 8 mice. J. Nucl. Med. 2010, 51:1576-1583.
31. Rominger A., Wagner E., Mille E., Boning G., Esmaeilzadeh M., Wangler B., Gildehaus F.J., Nowak S., Bruche A., Tatsch K., Bartenstein P., Cumming P. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse. Synapse 2010, 64:313-322.
32. Rousset O.G., Zaidi H. Correction for partial volume effects in emission tomography. Quantitative Analysis in Nuclear Medicine Imaging 2006, 236-271. Springer, New York. H. Zaidi (Ed.).
33. Rousset O.G., Ma Y., Evans A.C. Correction for partial volume effects in PET: principle and validation. J. Nucl. Med. 1998, 39:904-911.
34. Rousset O.G., Collins D.L., Rahmim A., Wong D.F. Design and implementation of an automated partial volume correction in PET: application to dopamine receptor quantification in the normal human striatum. J. Nucl. Med. 2008, 49:1097-1106.
35. Ryu Y.H., Liow J.S., Zoghbi S., Fujita M., Collins J., Tipre D., Sangare J., Hong J., Pike V.W., Innis R.B. Disulfiram inhibits defluorination of (18)F-FCWAY, reduces bone radioactivity, and enhances visualization of radioligand binding to serotonin 5-HT1A receptors in human brain. J. Nucl. Med. 2007, 48:1154-1161.
36. Schweinhardt P., Fransson P., Olson L., Spenger C., Andersson J.L. A template for spatial normalisation of MR images of the rat brain. J. Neurosci. Methods 2003, 129:105-113.
37. Shetty H.U., Zoghbi S.S., Simeon F.G., Liow J.S., Brown A.K., Kannan P., Innis R.B., Pike V.W. Radiodefluorination of 3-fluoro-5-(2-(2-[18F](fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a radioligand for imaging brain metabotropic glutamate subtype-5 receptors with positron emission tomography, occurs by glutathionylation in rat brain. J. Pharmacol. Exp. Ther. 2008, 327:727-735.
38. Shrestha S., Hirvonen J., Hines C.S., Henter I.D., Svenningsson P., Pike V.W., Innis R.B. Serotonin-1A receptors in major depression quantified using PET: controversies, confounds, and recommendations. Neuroimage 2012, 59:3243-3251.
39. Skinbjerg M., Liow J.S., Seneca N., Hong J., Lu S., Thorsell A., Heilig M., Pike V.W., Halldin C., Sibley D.R., Innis R.B. D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model. Neuroimage 2010, 50:1402-1407.
40. Slifstein M., Hwang D.R., Huang Y., Guo N., Sudo Y., Narendran R., Talbot P., Laruelle M. In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates. Psychopharmacology (Berl) 2004, 175:274-286.
41. Slifstein M., Kegeles L.S., Xu X., Thompson J.L., Urban N., Castrillon J., Hackett E., Bae S.A., Laruelle M., Abi-Dargham A. Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride. Synapse 2010, 64:350-362.
42. Tantawy M.N., Jones C.K., Baldwin R.M., Ansari M.S., Conn P.J., Kessler R.M., Peterson T.E. [(18)F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plot. Nucl. Med. Biol. 2009, 36:931-940.
43. Vandehey N.T., Moirano J.M., Converse A.K., Holden J.E., Mukherjee J., Murali D., Nickles R.J., Davidson R.J., Schneider M.L., Christian B.T. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol. J. Cereb. Blood Flow Metab. 2009, 30:994-1007.
44. Vucckovic M.G., Li Q., Fisher B., Nacca A., Leahy R.M., Walsh J.P., Mukherjee J., Williams C., Jakowec M.W., Petzinger G.M. Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: in vivo imaging with [(1)F]fallypride. Mov. Disord. 2010, 25:2777-2784.
45. Wu H.M., Hoh C.K., Choi Y., Schelbert H.R., Hawkins R.A., Phelps M.E., Huang S.C. Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies. J. Nucl. Med. 1995, 36:1714-1722.
46. Xi W., Tian M., Zhang H. Molecular imaging in neuroscience research with small-animal PET in rodents. Neurosci. Res. 2011, 70:133-143.
47. Yoder K.K., Mock B.H., Zheng Q.H., McCarthy B.P., Riley A.A., Hutchins G.D. Assessment of IP injection of [(18)F]fallypride for behavioral neuroimaging in rats. J. Neurosci. Methods 2011, 196:70-75.